Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.0B | 2.4B | 2.9B | 2.8B |
Cost of revenue | 2.7B | 2.2B | 2.5B | 2.4B |
Gross profit | 373.3M | 266.7M | 374.2M | 397.0M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 151.4M | 142.4M | 156.9M | 144.8M |
Other operating expenses | — | — | — | — |
Operating income | 134.0M | 30.9M | 118.6M | 154.1M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 37.6M | 33.5M | 37.4M | 40.3M |
Other income expense | 7.2M | 10.2M | 1.5M | 3.7M |
Pretax income | 103.5M | 7.7M | 82.7M | 117.4M |
Tax provision | 26.3M | -2.9M | 10.1M | 27.0M |
Net income | 77.3M | 10.6M | 72.6M | 90.4M |
Basic EPS | 1.1 | 0.1 | 1.0 | 1.2 |
Diluted EPS | 1.1 | 0.1 | 1.0 | 1.2 |
Basic average shares | 66.6M | 67.0M | 67.0M | 66.9M |
Diluted average shares | 67.3M | 67.8M | 67.8M | 67.6M |
EBITDA | 229.1M | 134.4M | 218.8M | 255.9M |
Net income from continuing op. | 77.3M | 10.6M | 72.6M | 90.4M |
Minority interests | -3.7M | -2.1M | -8.5M | -8.7M |
Preferred stock dividends | — | — | — | — |